Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void

AbbVie remained the top pharma TV ad spender with Humira in June, and Gilead Sciences continued its TV push for Biktarvy and Truvada. But one long-time list placeholder dropped out of sight: Pfizer’s Xeljanz.